Related Experiment Video
Updated: Aug 29, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia
Dae-Il Chang1, Naohisa Hosomi, Jacinta Lucero
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Abstract:
During focal cerebral ischemia, matrix metalloproteinase-2 (MMP-2) can contribute to the loss of microvessel integrity within ischemic regions by degrading the basal lamina. MMP-2 is secreted in latent form (pro-MMP-2), but the activation of pro-MMP-2 in the ischemic territory has not been shown. Immunohistochemical and in situ hybridization studies of the expression of the direct activators of MMP-2, MT1-MMP and MT3-MMP, and the indirect activation system tissue plasminogen activator, urokinase (u-PA), its receptor (u-PAR), and its inhibitor PAI-1 after middle cerebral artery occlusion/reperfusion were undertaken in basal ganglia samples from 26 adolescent male baboons. The expressions of all three MMPs, u-PA, u-PAR, and PA1-1, but not tissue plasminogen activator, were increased from 1 hour after middle cerebral artery occlusion in the ischemic core. mRNA transcripts confirmed the increases in latent MMP-2, u-PA, u-PAR, and PAI-1 antigen very early after middle cerebral artery occlusion. The expression patterns are consistent with secretion of pro-MMP-2 and its activators in the ischemic core, perhaps from separate cell compartments. The rapid and coordinate appearance of pro-MMP-2 and its activation apparatus suggest that in the primate striatum this protease may participate in matrix injury during focal cerebral ischemia.
Insights
Matrix metalloproteinase-2 (MMP-2) activation in the brain
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Matrix metalloproteinase-2 (MMP-2) degrades basal lamina, compromising microvessel integrity during focal cerebral ischemia.
- MMP-2 is secreted as a latent proenzyme (pro-MMP-2), and its activation mechanism in ischemic brain regions remains unclear.
Purpose of the Study:
- To investigate the expression and activation of MMP-2 and its activators in the primate brain following focal cerebral ischemia.
- To elucidate the early molecular events contributing to microvascular damage in ischemic stroke.
Main Methods:
- Immunohistochemistry and in situ hybridization were used to examine the expression of MMP-2, MT1-MMP, MT3-MMP, urokinase (u-PA), its receptor (u-PAR), and plasminogen activator inhibitor-1 (PAI-1).
- Samples were obtained from the basal ganglia of adolescent male baboons subjected to middle cerebral artery occlusion/reperfusion.
Main Results:
- Expressions of MMP-2, MT1-MMP, MT3-MMP, u-PA, u-PAR, and PAI-1 were significantly increased within 1 hour in the ischemic core after middle cerebral artery occlusion.
- mRNA transcripts confirmed early increases in latent MMP-2, u-PA, u-PAR, and PAI-1.
- Tissue plasminogen activator expression did not increase.
Conclusions:
- The findings suggest rapid secretion of pro-MMP-2 and its activators in the ischemic primate striatum.
- The coordinated early appearance of pro-MMP-2 and its activation system indicates its potential role in matrix degradation and microvascular injury during focal cerebral ischemia.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Role of Matrix Metalloproteases in Degradation of ECM
A...

